The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Regurin 20 mg coated tablets

20 milligram(s) Coated tablet

Madaus GmbHPA1288/001/001

Main Information

Trade NameRegurin 20 mg coated tablets
Active SubstancesTrospium chloride
Strength20 milligram(s)
Dosage FormCoated tablet
Licence HolderMadaus GmbH
Licence NumberPA1288/001/001

Group Information

ATC CodeG04BD Drugs for urinary frequency and incontinence
G04BD09 trospium

Status

Authorised/WithdrawnAuthorised
Licence Issued04/05/2001
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back